Description
Phase
Phase 3 - a treatment has shown activity against a particular disease, where it is either added to existing treatment or compared to the standard treatment.Inclusion and Exclusion Criteria
Please contact Poornima Murali to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Sites
-
California
- USC-Norris Comprehensive Cancer Center, Los Angeles, California, 90033
- Stanford Comprehensive Cancer Center, Stanford, California, 94305
-
Arizona
- Mayo Arizona, Scottsdale, Arizona, 85259
- Arizona Cancer Center, Tucson, Arizona, 85719
-
Idaho
- Kootenai Health - Kootenai Cancer Center, Coeur d`Alene, Idaho, 83814
-
Washington
- University of Washington Cancer Center, Seattle, Washington, 98109
-
Minnesota
- Mayo Rochester, Rochester, Minnesota, 55905
-
Iowa
- University of Iowa Health Care - University of Iowa Hospital, Iowa City, Iowa, 52242
-
Illinois
- Oncology Specialists, Park Ridge, Illinois, 60068
-
Georgia
- Winship Cancer Institute of Emory University, Midtown Campus, Atlanta, Georgia, 30322
-
Italy
- Azienda Ospedaliera Garibaldi, Catania, 95122
-
Canarias
- H.U. Canarias, Hospital Universitario de Canarias. Servicio de Oncología Médica, Tenerife, Canarias, 38320
Powered by
SC CTSI